trending Market Intelligence /marketintelligence/en/news-insights/trending/QYDFqh3ghHUsT2GJfQA9rg2 content esgSubNav
In This List

Quidel adds director

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Quidel adds director

Quidel Corp. appointed Edward Michael to the board.

Michael serves as the co-founder and managing partner of LionBird (Ventures) Ltd., a venture capital firm. In addition, he is a board member of NeuMoDx Molecular Inc., a molecular diagnostics company. Michael was also executive vice president of diagnostic products at Abbott Laboratories.

Quidel also expanded the board size from eight to nine directors.

San Diego-based Quidel develops, manufactures and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology.